In addition, weekly dosing of PCPS/STAT3 siRNA for four weeks did not cause signs of sub-acute toxicity based on changes in body weight, hematology, blood chemistry, and major organ histology.
The results suggest that we have developed a safe vehicle for effective delivery of gene silencing agents.